{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:56:36Z","timestamp":1790873796441,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Mucuna pruriens<\/jats:italic>\n                    (MP), or velvet bean, has been used as an alternative medicine in India for over 4500 years, predominantly due to the natural abundance of the non-protein amino acid L-3,4-dihydroxyphenylalanine (L-DOPA). L-DOPA (levodopa) is used to treat Parkinson\u2019s disease (PD), a condition in which the progressive loss of dopaminergic neurons causes dopamine deficiency and impaired motor function. Although L-DOPA increases dopamine synthesis in the remaining dopaminergic neurones in the PD brain, the rate of disease progression appears to remain unchanged. Some studies have demonstrated improved outcomes in patients taking MP preparations compared to those undergoing traditional L-DOPA therapy. There is evidence that the canonical amino acids and L-DOPA precursors L-phenylalanine (L-Phe) and L-tyrosine (L-Tyr) can increase dopamine synthesis and also protect against the mistaken incorporation of L-DOPA into proteins during protein synthesis. The current study developed and validated a sensitive HILIC\u2013TQMS method for the quantification of L-DOPA and related amino acids in MP preparations. Analysis revealed that L-DOPA levels were 66.2% to 82.7% of the values reported by manufacturers. Tyr and Phe were present in both free and protein bound forms in all 5 preparations analysed, potentially offering protection against the mistaken incorporation of L-DOPA into proteins and promoting increased dopamine synthesis. These findings suggest that the additional reported benefits of MP supplements for PD treatment might, in part, be attributable to the presence of these amino acids, further supporting the need to investigate the administration of L-DOPA and its cognate amino acid in symptomatic treatment of PD.\n                  <\/jats:p>","DOI":"10.1007\/s00726-025-03491-0","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:36:10Z","timestamp":1769150170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of amino acids in Mucuna pruriens supplements using hydrophilic interaction liquid chromatography-tandem mass spectrometry"],"prefix":"10.1007","volume":"58","author":[{"given":"Connor R.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake P.","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"3","key":"3491_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03033137","volume":"5","author":"M Asanuma","year":"2003","unstructured":"Asanuma M, Miyazaki I, Ogawa N (2003) Dopamine- or l-dopa-induced neurotoxicity: the role of dopamine Quinone formation and tyrosinase in a model of parkinson\u2019s disease. Neurotox Res 5(3):165\u2013176.","journal-title":"Neurotox Res"},{"issue":"7\u20138","key":"3491_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.fitote.2008.05.008","volume":"79","author":"A Bhaskar","year":"2008","unstructured":"Bhaskar A, Vidhya VG, Ramya M (2008) Hypoglycemic effect of mucuna pruriens seed extract on normal and streptozotocin-diabetic rats. Fitoterapia 79(7\u20138):539\u2013543.","journal-title":"Fitoterapia"},{"key":"3491_CR3","doi-asserted-by":"crossref","unstructured":"Boonmongkol T, Phokaewvarangkul O, Vimolmangkang S, Wattanavijitkul T, Komenkul V, Bhidayasiri R (2025) Comparative efficacy of mucuna pruriens and conventional levodopa in parkinson\u2019s disease: a randomized controlled trial on pharmacokinetics and clinical perspectives from asia. J Neural Transm (Vienna).","DOI":"10.1007\/s00702-025-02914-2"},{"issue":"7","key":"3491_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.neuint.2012.07.012","volume":"61","author":"Z Brodnik","year":"2012","unstructured":"Brodnik Z, Bongiovanni R, Double M, Jaskiw GE (2012) Increased tyrosine availability increases brain regional Dopa levels in vivo. Neurochem Int 61(7):1001\u20131006.","journal-title":"Neurochem Int"},{"issue":"4","key":"3491_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1212\/WNL.39.4.552","volume":"39","author":"JH Carter","year":"1989","unstructured":"Carter JH, Nutt JG, Woodward WR, Hatcher LF, Trotman TL (1989) Amount and distribution of dietary protein affects clinical response to Levodopa in parkinson\u2019s disease. Neurology 39(4):552\u2013556.","journal-title":"Neurology"},{"key":"3491_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jns.2016.04.001","volume":"365","author":"E Cassani","year":"2016","unstructured":"Cassani E, Cilia R, Laguna J, Barichella M, Contin M, Cereda E, Isaias IU, Sparvoli F, Akpalu A, Budu KO, Scarpa MT, Pezzoli G (2016) Mucuna pruriens for parkinson\u2019s disease: low-cost Preparation method, laboratory measures and pharmacokinetics profile. J Neurol Sci 365:175\u2013180.","journal-title":"J Neurol Sci"},{"issue":"1","key":"3491_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.expneurol.2011.09.029","volume":"238","author":"SW Chan","year":"2012","unstructured":"Chan SW, Dunlop RA, Rowe A, Double KL, Rodgers KJ (2012) L-dopa is incorporated into brain proteins of patients treated for parkinson\u2019s disease, inducing toxicity in human neuroblastoma cells in vitro. Exp Neurol 238(1):29\u201337","journal-title":"Exp Neurol"},{"issue":"5","key":"3491_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.biocel.2004.09.009","volume":"37","author":"SJ Chinta","year":"2005","unstructured":"Chinta SJ, Andersen JK (2005) Dopaminergic neurons. Int J Biochem Cell Biol 37(5):942\u2013946.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"3491_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1212\/WNL.0000000000004175","volume":"89","author":"R Cilia","year":"2017","unstructured":"Cilia R, Laguna J, Cassani E, Cereda E, Pozzi NG, Isaias IU, Contin M, Barichella M, Pezzoli G (2017) Mucuna pruriens in parkinson disease: a double-blind, randomized, controlled, crossover study. Neurology 89(5):432\u2013438","journal-title":"Neurology"},{"issue":"10","key":"3491_CR10","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jamaneurol.2022.2184","volume":"79","author":"PA Cohen","year":"2022","unstructured":"Cohen PA, Avula B, Katragunta K, Khan I (2022) Levodopa content of mucuna pruriens supplements in the Nih dietary supplement label database. JAMA Neurol 79(10):1085\u20131086","journal-title":"JAMA Neurol"},{"issue":"12","key":"3491_CR11","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1042\/bj0312149","volume":"31","author":"M Damodaran","year":"1937","unstructured":"Damodaran M, Ramaswamy R (1937) Isolation of l-3:4-dihydroxyphenylalanine from the seeds of mucuna pruriens. Biochem J 31(12):2149\u20132152.","journal-title":"Biochem J"},{"issue":"11","key":"3491_CR12","doi-asserted-by":"publisher","first-page":"e11835","DOI":"10.1016\/j.heliyon.2022.e11835","volume":"8","author":"MY Dimitry","year":"2022","unstructured":"Dimitry MY, Marie Therese BA, Josiane Edith DM, Emmanuel PA, Armand AB, Nicolas NY (2022) Hypolipidemic and antioxidant effects of vegetal milk produced with mucuna pruriens l. Seed in rats fed a high-fat diet. Heliyon 8(11):e11835","journal-title":"Heliyon"},{"issue":"5","key":"3491_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/iub.189","volume":"61","author":"RA Dunlop","year":"2009","unstructured":"Dunlop RA, Brunk UT, Rodgers KJ (2009) Oxidized proteins: mechanisms of removal and consequences of accumulation. IUBMB Life 61(5):522\u2013527","journal-title":"IUBMB Life"},{"issue":"1","key":"3491_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/BJ20100682","volume":"435","author":"RA Dunlop","year":"2011","unstructured":"Dunlop RA, Brunk UT, Rodgers KJ (2011) Proteins containing oxidized amino acids induce apoptosis in human monocytes. Biochem J 435(1):207\u2013216","journal-title":"Biochem J"},{"key":"3491_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1006\/exnr.1996.6379","volume":"144","author":"JD Eldsworth","year":"1997","unstructured":"Eldsworth JD, Roth HR (1997) Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of parkinson\u2019s disease. Exp Neurol 144:4\u20139","journal-title":"Exp Neurol"},{"issue":"Pt 5","key":"3491_CR16","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and parkinson\u2019s disease: substantia Nigra regional selectivity. Brain 114(Pt 5):2283\u20132301","journal-title":"Brain"},{"key":"3491_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.biochem.68.1.355","volume":"68","author":"PF Fitzpatrick","year":"1999","unstructured":"Fitzpatrick PF (1999) Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 68:355\u2013381","journal-title":"Annu Rev Biochem"},{"key":"3491_CR18","doi-asserted-by":"publisher","first-page":"105624","DOI":"10.1016\/j.biocel.2019.105624","volume":"117","author":"S Giannopoulos","year":"2019","unstructured":"Giannopoulos S, Samardzic K, Raymond BBA, Djordjevic SP, Rodgers KJ (2019) L-dopa causes mitochondrial dysfunction in vitro: a novel mechanism of l-dopa toxicity uncovered. Int J Biochem Cell Biol 117:105624","journal-title":"Int J Biochem Cell Biol"},{"issue":"18","key":"3491_CR19","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1021\/bi00069a012","volume":"32","author":"SP Gieseg","year":"1993","unstructured":"Gieseg SP, Simpson JA, Charlton TS, Duncan MW, Dean RT (1993) Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. Biochemistry 32(18):4780\u20134786","journal-title":"Biochemistry"},{"issue":"10","key":"3491_CR48","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0024-3205(82)90596-3","volume":"30","author":"JH Growdon","year":"1982","unstructured":"Growdon JH, Melamed E, Logue M, Hefti F, Wurtman RJ (1982) Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson\u2019s disease. Life Sci 30(10):827\u201332","journal-title":"Life Sci"},{"issue":"24","key":"3491_CR21","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.3390\/molecules27248797","volume":"27","author":"DG Han","year":"2022","unstructured":"Han DG, Bae MJ, An BJ (2022) Anti-inflammatory activity of velvet bean (mucuna pruriens) substances in lps-stimulated raw 264.7 macrophages. Molecules 27(24):8797","journal-title":"Molecules"},{"key":"3491_CR20","doi-asserted-by":"publisher","first-page":"1319419","DOI":"10.1155\/padi\/1319419","volume":"2025","author":"F Hammoud","year":"2025","unstructured":"Hammoud F, Ismail A, Zaher R, El Majzoub R, Abou-Abbas L (2025) Mucuna pruriens treatment for parkinson disease: a systematic review of clinical trials. Parkinsons Dis 2025:1319419","journal-title":"Parkinsons Dis"},{"key":"3491_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.arr.2016.03.005","volume":"27","author":"BR Ipson","year":"2016","unstructured":"Ipson BR, Fisher AL (2016) Roles of the tyrosine isomers meta-tyrosine and ortho-tyrosine in oxidative stress. Ageing Res Rev 27:93\u2013107","journal-title":"Ageing Res Rev"},{"issue":"2","key":"3491_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12640-009-9011-7","volume":"15","author":"S Kasture","year":"2009","unstructured":"Kasture S, Pontis S, Pinna A, Schintu N, Spina L, Longoni R, Simola N, Ballero M, Morelli M (2009) Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson\u2019s disease. Neurotox Res. 15(2):111\u201322","journal-title":"Neurotox Res."},{"issue":"12","key":"3491_CR49","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1136\/jnnp.2003.028761","volume":"75","author":"R Katzenschlager","year":"2004","unstructured":"Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, Timmermann L, Van der Giessen R, Lees AJ (2004) Mucuna pruriens in Parkinson\u2019s disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 75(12):1672\u20131677","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"3491_CR23","first-page":"103","volume":"70","author":"S Kaufman","year":"1995","unstructured":"Kaufman S (1995) Tyrosine hydroxylase. Adv Enzymol Relat Areas Mol Biol 70:103\u2013220.","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"issue":"2","key":"3491_CR24","first-page":"138","volume":"8","author":"C Kavitha","year":"2024","unstructured":"Kavitha C, Thangamani C (2024) Amazing bean mucuna pruriens: a comprehensive review. J Med Plants 8(2):138\u2013143","journal-title":"J Med Plants"},{"issue":"15","key":"3491_CR25","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.3390\/ijms21155421","volume":"21","author":"U Kolukisaoglu","year":"2020","unstructured":"Kolukisaoglu U (2020) D-amino acids in plants: Sources, metabolism, and functions. Int J Mol Sci 21(15):5421","journal-title":"Int J Mol Sci"},{"key":"3491_CR26","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1007\/s11010-025-05324-w","volume":"480","author":"SR Kulkarni","year":"2025","unstructured":"Kulkarni SR, Thokchom B, Abbigeri MB, Bhavi SM, Singh SR, Metri N, Yarajarla RB (2025) The role of l-dopa in neurological and neurodegenerative complications: a review. Mol Cell Biochem 480:5221\u20135242","journal-title":"Mol Cell Biochem"},{"key":"3491_CR27","doi-asserted-by":"publisher","first-page":"125171","DOI":"10.1016\/j.talanta.2023.125171","volume":"267","author":"X Li","year":"2024","unstructured":"Li X, Liu Z, Li Z, Xiong X, Zhang X, Yang C, Zhao L, Zhao R (2024) A simple, rapid and sensitive hilic lc-ms\/ms method for simultaneous determination of 16 purine metabolites in plasma and urine. Talanta 267:125171.","journal-title":"Talanta"},{"issue":"7","key":"3491_CR50","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.parkreldis.2010.04.015","volume":"16","author":"CA Lieu","year":"2010","unstructured":"Lieu CA, Kunselman AR, Manyam BV, Venkiteswaran K, Subramanian T (2010) A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism Relat Disord. 16(7):458\u201365","journal-title":"Parkinsonism Relat Disord."},{"key":"3491_CR51","doi-asserted-by":"crossref","unstructured":"Lieu CA, Venkiteswaran K, Gilmour TP, Rao AN, Petticoffer AC, Gilbert EV, Deogaonkar M, Manyam BV, Subramanian T(2012) The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate. Evid Based Complement Alternat Med. 840247.","DOI":"10.1155\/2012\/840247"},{"issue":"7708","key":"3491_CR28","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0140-6736(71)91608-4","volume":"1","author":"WE Martin","year":"1971","unstructured":"Martin WE (1971) Tyrosine hydroxylase deficiency: a unifying concenpt of parkinsonism. Lancet 1(7708):1050\u20131051.","journal-title":"Lancet"},{"issue":"4","key":"3491_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/BF01247323","volume":"47","author":"E Melamed","year":"1980","unstructured":"Melamed E, Glaeser B, Growdon JH, Wurtman RJ (1980) Plasma tyrosine in normal humans: effects of oral tyrosine and protein-containing meals. J Neural Transm 47(4):299\u2013306.","journal-title":"J Neural Transm"},{"issue":"9","key":"3491_CR30","doi-asserted-by":"publisher","first-page":"17117","DOI":"10.1038\/nmicrobiol.2017.117","volume":"2","author":"K Mohler","year":"2017","unstructured":"Mohler K, Ibba M (2017) Translational fidelity and mistranslation in the cellular response to stress. Nat Microbiol 2(9):17117.","journal-title":"Nat Microbiol"},{"issue":"1","key":"3491_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2019.10.005","volume":"225","author":"DR Montagna","year":"2020","unstructured":"Montagna DR, Duarte A, Todero MF, Ruggiero RA, Isturiz M, Rearte B (2020) Meta-tyrosine modulates the immune response induced by bacterial endotoxins. Immunobiology 225(1):151856","journal-title":"Immunobiology"},{"issue":"10","key":"3491_CR32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.chembiol.2011.08.008","volume":"18","author":"N Moor","year":"2011","unstructured":"Moor N, Klipcan L, Safro MG (2011) Bacterial and eukaryotic phenylalanyl-trna synthetases catalyze misaminoacylation of trna(phe) with 3,4-dihydroxy-l-phenylalanine. Chem Biol 18(10):1221\u20131229","journal-title":"Chem Biol"},{"issue":"2","key":"3491_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0003-2697(90)90112-M","volume":"189","author":"K Muramoto","year":"1990","unstructured":"Muramoto K, Kamiya H (1990) Recovery of Tryptophan in peptides and proteins by high-temperature and short-term acid hydrolysis in the presence of phenol. Anal Biochem 189(2):223\u2013230","journal-title":"Anal Biochem"},{"key":"3491_CR34","doi-asserted-by":"publisher","first-page":"11078","DOI":"10.1038\/srep11078","volume":"5","author":"H Pulikkalpura","year":"2015","unstructured":"Pulikkalpura H, Kurup R, Mathew PJ, Baby S (2015) Levodopa in mucuna pruriens and its degradation. Sci Rep 5:11078","journal-title":"Sci Rep"},{"issue":"12","key":"3491_CR35","first-page":"522","volume":"10","author":"SN Rai","year":"2020","unstructured":"Rai SN, Chaturvedi VK, Singh P, Singh BK, Singh MP (2020) Mucuna pruriens in parkinson\u2019s and in some other diseases: recent advancement and future prospective. Biotech 10(12):522","journal-title":"Biotech"},{"key":"3491_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.expneurol.2013.12.010","volume":"253","author":"KJ Rodgers","year":"2014","unstructured":"Rodgers KJ (2014) Non-protein amino acids and neurodegeneration: the enemy within. Exp Neurol 253:192\u2013196","journal-title":"Exp Neurol"},{"issue":"9","key":"3491_CR36","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S1357-2725(00)00034-0","volume":"32","author":"KJ Rodgers","year":"2000","unstructured":"Rodgers KJ, Dean RT (2000) The metabolism of protein-bound Dopa in mammals. Int J Biochem Cell Biology 32(9):945\u2013955","journal-title":"Int J Biochem Cell Biology"},{"issue":"8","key":"3491_CR39","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.biocel.2008.01.009","volume":"40","author":"KJ Rodgers","year":"2008","unstructured":"Rodgers KJ, Shiozawa N (2008) Misincorporation of amino acid analogues into proteins by biosynthesis. Int J Biochem Cell Biol 40(8):1452\u20131466","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"3491_CR37","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0891-5849(02)00768-2","volume":"32","author":"KJ Rodgers","year":"2002","unstructured":"Rodgers KJ, Wang H, Fu S, Dean RT (2002) Biosynthetic incorporation of oxidized amino acids into proteins and their cellular proteolysis. Free Radic Biol Med 32(8):766\u2013775","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"3491_CR38","first-page":"29","volume":"238","author":"KJ Rodgers","year":"2006","unstructured":"Rodgers KJ, Hume PM, Morris JG, Dean RT (2006) Evidence for l-dopa incorporation into cell proteins in patients treated with Levodopa. J Neurochem 238(1):29\u201337","journal-title":"J Neurochem"},{"issue":"4","key":"3491_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pbj.2016.08.001","volume":"1","author":"AS Rua Rafael","year":"2016","unstructured":"Rua Rafael AS, Pinto Barbosa JM, Silva Le\u00e3o Rosas MJ, Lobo Almeida Garrett MC (2016) Parkinson\u2019s disease and development of levodopa induced motor complications: Influence of baseline features and first medical approach. Porto Biomed J 1(4):136\u2013141","journal-title":"Porto Biomed J"},{"issue":"8","key":"3491_CR42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/separations9080224","volume":"9","author":"C Tesoro","year":"2022","unstructured":"Tesoro C, Lelario F, Ciriello R, Bianco G, Di Capua A, Acquavia MA (2022) An overview of methods for l-dopa extraction and analytical determination in plant matrices. Separations 9(8):224","journal-title":"Separations"},{"issue":"10","key":"3491_CR43","doi-asserted-by":"publisher","first-page":"e4952","DOI":"10.1002\/jms.4952","volume":"58","author":"C Tesoro","year":"2023","unstructured":"Tesoro C, Lelario F, Ciriello R, Bianco G, Acquavia MA, Montoro P, Crescenzi MA, Gregori E, Dell\u2019Agli M, Piazza S, Guerrieri A, Di Capua A (2023) A validated lc-ms\/ms method for quantitative determination of l-dopa in fagioli di sarconi beans (phaseolus vulgaris l.). J Mass Spectrom 58(10):e4952","journal-title":"J Mass Spectrom"},{"key":"3491_CR44","doi-asserted-by":"publisher","first-page":"462530","DOI":"10.1016\/j.chroma.2021.462530","volume":"1655","author":"JP Violi","year":"2021","unstructured":"Violi JP, Bishop DP, Padula MP, Westerhausen MT, Rodgers KJ (2021) Acetonitrile adduct analysis of underivatised amino acids offers improved sensitivity for hydrophilic interaction liquid chromatography tandem mass-spectrometry. J Chromatogr A 1655:462530","journal-title":"J Chromatogr A"},{"key":"3491_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40734-016-0036-9","volume":"3","author":"T Virmani","year":"2016","unstructured":"Virmani T, Tazan S, Mazzoni P, Ford B, Greene PE (2016) Motor fluctuations due to interaction between dietary protein and levodopa in parkinson\u2019s disease. J Clin Mov Disord 3:8","journal-title":"J Clin Mov Disord"},{"issue":"146","key":"3491_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1126\/science.185.4146.183","volume":"185","author":"RJ Wurtman","year":"1974","unstructured":"Wurtman RJ, Larin F, Mostafapour S, Fernstrom JD (1974) Brain catechol synthesis: Control by train tyrosine concentration. Science 185(146):183\u2013184","journal-title":"Science"},{"issue":"2","key":"3491_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5511\/plantbiotechnology.21.1126a","volume":"39","author":"E Yumoto","year":"2022","unstructured":"Yumoto E, Yanagihara N, Asahina M (2022) The simple and rapid quantification method for l-3,4-dihydroxyphenylalanine (l-dopa) from plant sprout using liquid chromatography-mass spectrometry. Plant Biotechnol (Tokyo) 39(2):199\u2013204","journal-title":"Plant Biotechnol (Tokyo)"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-025-03491-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-025-03491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-025-03491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:02:42Z","timestamp":1770397362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-025-03491-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3491"],"URL":"https:\/\/doi.org\/10.1007\/s00726-025-03491-0","relation":{},"ISSN":["1438-2199"],"issn-type":[{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6"}}